Insider: Warren Eric Chief Commercial Officer - Esperion Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 370,218 | 0 | 370,218 |
| Value | $981,077.70 | $0.00 | $981,077.70 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 04/17/2025 | DDS | 108 | Direct | COM | $0.98 | $105.62 | 370,218 |
| 03/18/2025 | DDS | 2,433 | Direct | COM | $1.49 | $3,617.87 | 370,326 |
| 02/19/2025 | DDS | 239 | Direct | COM | $1.87 | $446.45 | 159,759 |
| 01/17/2025 | DDS | 123 | Direct | COM | $2.26 | $277.98 | 159,998 |
| 12/17/2024 | DDS | 2,234 | Direct | COM | $2.43 | $5,426.39 | 160,121 |
| 11/19/2024 | DDS | 197 | Direct | COM | $2.17 | $426.51 | 162,355 |
| 10/17/2024 | DDS | 107 | Direct | COM | $2.12 | $226.73 | 162,552 |
| 09/17/2024 | DDS | 2,608 | Direct | COM | $1.78 | $4,650.06 | 162,659 |
| 08/19/2024 | DDS | 211 | Direct | COM | $1.95 | $410.61 | 165,267 |
| 07/17/2024 | DDS | 108 | Direct | COM | $2.59 | $279.40 | 165,478 |
| 06/18/2024 | DDS | 2,540 | Direct | COM | $2.86 | $7,254.24 | 165,586 |
| 05/17/2024 | DDS | 192 | Direct | COM | $2.48 | $476.74 | 168,126 |
| 09/20/2023 | DDS | 742 | Direct | COM | $1.25 | $923.79 | 68,318 |
| 08/18/2023 | DDS | 243 | Direct | COM | $1.41 | $343.60 | 69,060 |
| 07/19/2023 | DDS | 106 | Direct | COM | $1.59 | $168.01 | 69,303 |
| 06/21/2023 | DDS | 603 | Direct | COM | $1.48 | $894.25 | 69,409 |
| 05/17/2023 | DDS | 219 | Direct | COM | $1.62 | $355.66 | 70,012 |
| 04/19/2023 | DDS | 115 | Direct | COM | $1.28 | $146.97 | 70,231 |
| 03/17/2023 | DDS | 526 | Direct | COM | $1.78 | $937.49 | 70,346 |
| 03/07/2023 | DDS | 5,090 | Direct | COM | $5.06 | $25,729.95 | 48,572 |
| 10/18/2022 | DDS | 107 | Direct | COM | $7.69 | $822.83 | 53,662 |
| 09/19/2022 | DDS | 255 | Direct | COM | $6.92 | $1,764.86 | 53,769 |
| 08/31/2022 | AAP | 1,000 | Direct | COM | $7.46 | $7,460.00 | 54,024 |
| 08/17/2022 | DDS | 199 | Direct | COM | $6.82 | $1,356.19 | 53,024 |
| 07/19/2022 | DDS | 431 | Direct | COM | $6.58 | $2,836.84 | 53,223 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research